Difficulty: Medium
Average Score: 84%
Practice
Which of the following antiparkinsonism drugs is an anticholinergic agent?
Correct answer
C
Rationale
In this question, the correct answer is C) Trihexyphenidyl. Trihexyphenidyl is an anticholinergic agent commonly used in the treatment of Parkinson's disease to help control tremors and muscle stiffness.
Amantadine (A) is not an anticholinergic agent; it works by increasing the release of dopamine in the brain. Selegiline (B) is a monoamine oxidase inhibitor and does not exhibit anticholinergic effects. Bromocriptine (D) is a dopamine agonist used to treat Parkinson's disease by acting on dopamine receptors, but it is not an anticholinergic drug.
Understanding the specific mechanisms of action of different antiparkinsonism drugs is crucial for healthcare professionals to make informed decisions when treating patients with Parkinson's disease. Knowing the distinctions between these drugs can help in selecting the most appropriate medication based on the patient's symptoms and individual needs.
Amantadine (A) is not an anticholinergic agent; it works by increasing the release of dopamine in the brain. Selegiline (B) is a monoamine oxidase inhibitor and does not exhibit anticholinergic effects. Bromocriptine (D) is a dopamine agonist used to treat Parkinson's disease by acting on dopamine receptors, but it is not an anticholinergic drug.
Understanding the specific mechanisms of action of different antiparkinsonism drugs is crucial for healthcare professionals to make informed decisions when treating patients with Parkinson's disease. Knowing the distinctions between these drugs can help in selecting the most appropriate medication based on the patient's symptoms and individual needs.